HEPALINK announced that on December 31, 2024, it signed a distribution agreement with YONGLI Pharmaceutical, granting HEPALINK the license to commercialize Gabapentin capsules in the USA. HEPALINK will purchase the symbol Pharmaceutical from YONGLI Pharmaceutical at an agreed price and will be responsible for the commercialization of the symbol Pharmaceutical in the American market. Gabapentin is a commonly used antiepileptic drug that is widely used to treat neuropathic pain and other painful diseases. This cooperation reflects and explores HEPALINK's commitment to international Operation and its strategic assistance for Chinese pharmaceutical companies to enter the European and American markets. The company will be responsible for the commercialization of the symbol Pharmaceutical in the cooperation area and will bear the related costs, but there is uncertainty about whether the commercialization promotion will achieve the expected benefits.
- Latest
- Detail
海普瑞：与永太药业签订分销协议 获加巴喷丁胶囊美国商业化许可
HEPALINK: Signed a distribution agreement with YONGLI Pharmaceutical, obtaining commercialization license for Gabapentin capsules in the USA.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
02:51
JPMorgan's trading team: The "possibility of a bear market is extremely low" due to strong economic growth.
02:39
Investment firm New Street Research has upgraded Tesla's rating to buy, with a Target Price of 460 dollars.
TSLA-1.28%
02:34
After counting the electoral votes, the USA Congress confirmed that the elected president Donald Trump won the 2024 election.
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.